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Authors 
Study 
type 
Number of patients OCT 
type 
Objective and key findings Limitations 
NMO(-SD) MS HC 
Merle 
(2008)
47
 
CS 15  15 23 TD, 
St 
- RNFL in NMO and differences to MS 
- Average pRNFL reduced in NMO compared to HC (p<0.0001) and MS (p=0.01) 
- Visual acuity in NMO is stronger impaired than in MS 
- pRNFL correlates with VA, CS, VF, visual EDSS, No of ON episodes  
- NON eyes no 
statistical analysis  
- No macula analysis 
De Seze 
(2008)
46
 
CS, P 35 (29 NMO 
and 6 
NMOSD) 
 
- 15 TD, 
St 
- pRNFL comparison of NMO and HC and visual impairment 
- Average pRNFL reduced in NMO (p<0.001) 
- OCT correlates with VF, VA/VEP, and EDSS 
- Mix of ON and NON 
eyes 
- No MS 
- No macula analysis 
Naismith 
(2009)
43
  
CS 22 (17 NMO, 5 
NMOSD)  
 
47 - TD, 
St 
- pRNFL comparison of NMO and MS  and visual impairment 
- Average pRNFL reduced in NMO compared to MS (p<0.01) 
- Average pRNFL reduced in NMO-ON compared to MS-ON (p<0.05) 
- I, S, N quadrant in NMO more affected than in MS, T quadrant NMO similar to MS 
- RNFL in MS-NON thinner than in NMO-NON (p<0.05) 
- No macula analysis 
Ratchford 
(2009) 
42
 
MC, 
CS 
26  
(19 NMO, 7 
NMOSD with 
ON), 
17 LETM  
378  77 TD, 
St 
- pRNFL and TMV and visual parameters for differentiation between NMO and 
MS 
- Average pRNFL, TMV and LCVA reduced in NMO-ON compared to HC (all 
p<0.0001) 
- Average pRNFL and TMV reduced in NMO-ON compared to MS-ON (pRNFL: 
p<0.0001; TMV: p=0.001) 
- No significant difference for pRNFL, TMV and LCVA between NMO-NON and HC 
- Correlations with VA and CS: NMO also functional stronger affected 
- No RNFL quadrant 
analysis 
Green 
(2009)
44
 
CS 16 16 - TD, 
St 
- Distinctive retinal nerve fibre layer and vascular changes in neuromyelitis 
optica following optic neuritis 
- More vascular changes in NMO compared to MS  
- Average pRNFL reduced in NMO compared to MS 
- In NMO all quadrants affected, in MS mainly temporal 
- In results no numbers 
for OCT parameters 
- No macula analysis 
Nakamur
a 
(2010)
45
 
CS, IV 18  
(14 NMO,  
4 NMOSD -
ON) 
14 - TD, 
St 
- Comparison of RNFL between NMO and MS and effect of high-dose 
intravenous methylprednisolone (HIMP) 
 - Average pRNFL reduced in NMO-ON compared to MS-ON (p = 0.0006) 
- All pRNFL quadrants reduced in NMO–ON compared to MS-ON (S, I: p<0.001, N, 
T: n.s.) 
- RNFL correlates with VA in both MS and NMO  
- HIMP helped to preserve the RNFL 
- NON eyes not 
statistically analyzed 
- No macula analysis 
Monteiro 
(2012) 
54
 
CS, P 
 
33 NMOSD 
28 LETM-NON 
 
60 41 SD, 
To 
RNFL and macular thickness comparison of NMO and MS 
- Average pRNFL reduced in NMO-ON compared to MS-ON (p=0.02) and HC 
(p<0.0001) 
- 15 NMO eyes 
excluded due to poor 
vision 
- Average pRNFL reduced in LETM compared to HC (p<0.001) 
- No difference in macular thickness in NMO-ON compared to MS-ON 
- OCT correlates with VF  
- Only NMO eyes with 
ON were studied 
 
Syc 
(2012) 
55
 
L, MC 22 98 72 SD, 
Ci 
- Six months follow up study of inner-retinal layer analysis after ON in MS and 
NMO  
Cross-sectional: 
- Average pRNFL reduced in NMO-ON compared to MS-ON (p<0.001) 
- No difference in average pRNFL in NMO-NON compared to MS-NON 
- GCIP in MS-ON, MS-NON, NMO-ON and NMO-NON(!) reduced compared to HC 
Longitudinal: 
- Thinning of the GCIP in eyes affected by acute ON 3 and 6 months after onset 
(p<0.001) 
- In contrast to RNFL, no swelling of GCL in acute ON 
- Compared only ON vs. 
NON eye 
Bouyon 
(2013) 
52
 
L 30 - - TD, 
St 
- OCT and visual follow-up in NMO (2 visits) 
- RNFL decrease (p=0.006) 
- TMV decrease n.s. 
- VA change n.s.  
- No HC  
- No MS 
Fernande
s (2013) 
51
 
CS, O, 
P 
 
29 NMO, 29 
LETM 
73 45 SD, 
To 
- Evaluation of Inner Retinal Layers in Patients with Multiple Sclerosis or 
Neuromyelitis Optica  
- mRNFL reduced in all (even LETM!) patient groups compared to HC 
- GCIP reduced in NMO, MS-ON, MS-NON compared to HC 
- INL in NMO thicker than in MS-ON 
- No difference in mRNFL and GCIP between NMO and MS-ON patients 
- NMO group both ON 
and NON-eyes? (not 
clear) 
- No pRNFL analysis 
- No TMV analysis 
Gelfand 
(2013)
49
 
O, R 
 
23 NMO, 2 
NMOSD with 
ON 
- - SD, 
Sp 
- MME in NMO (retinal layer analysis) 
- MME in 20% of NMO patients 
- MME only in eyes with previous ON 
- pRNFL thinner in MME eyes compared with all NMO eyes without MME (p = 0.02);  
- TMV comparisons n.s. 
- VA reduced in MME eyes compared to non-MME (p=0.02) 
- No MS  
Sotirchos 
(2013) 
56
 
CS 39 (31 
NMO&NMOS
D with ON, 8 
AQP4+ LETM) 
- 39 SD, 
Ci 
- Intra-retinal layer analysis in NMO patients with focus on MME  
- MME in 26% of NMO patients 
- MME only in ON eyes 
- MME eyes in relation to non-MME ON eyes:  
 Lower pRNFL (p=0.04), mRNFL thickness (p =0.004), GCIP (p=0.007) 
 Higher INL thickness (p = 0.001) 
 Lower high- and low-contrast VA  
- No TMV analysis 
Schneide
r (2013) 
CS 
 
17 (13 NMO, 4 
NMOSD) 
17 17 SD, 
Sp 
- One-to-one matching inner retinal layer comparison of NMO, MS and HC 
eyes with focus on ON 
 
 
Legend: CS: cross-sectional; P: prospective; MC: multi-center; O: observational; L: longitudinal; IV: interventional; RS: retrospective; CSS: case series study; TD: 
Time Domain; SD: Spectral Domain OCT; St: Stratus TD-OCT, Carl Zeiss Meditec; Ci: Cirrus HD-OCT, Carl Zeiss Meditec; Sp: Spectralis OCT, Heidelberg 
Engineering; NMOSD: neuromyelitis optica spectrum disorder; MS: multiple sclerosis; LETM: longitudinally extensive transverse myelitis; ON: optic neuritis; 
50
  -  Average pRNFL and TMV reduced in NMO-ON compared to MS-ON (pRNFL: 
p<0.001, TMV p=0.019) 
- In MS, RNFL loss predominantly temporal, while in NMO loss evenly in all 
quadrants 
- NMO-NON eyes: no OCT parameter reduced compared to HC  
- Four eyes from three NMO patients affected by MME 
Lange 
(2013) 
48
 
CS 25 (15 NMO, 
10 NMOSD) 
25 50 SD, 
Sp 
- RNFL marker for NMO? 
- Average pRNFL reduced in NMO-ON compared to HC (p<0.0001)  
- No difference in RNFL between NMO-NON and HC (p=0.56) 
- No significant differences between pRNFL of NMO and MS eyes with 1 attack of 
ON 
- No macular analysis 
Park 
(2013) 
57
 
CP, O, 
CSS 
 
19 (not 
Wingerchuk) 
15 25 SD, 
Sp 
- Retinal layer analysis in different macular locations in ON eyes from 
different diseases 
- Also included 22 patients with isolated ON  
- Included only ON eyes and only one eye per patient  
- pRNFL different between isolated ON, NMO and MS in T (p=0.029) and I 
(p=0.013), average, S, N n.s. 
- Unclear statistical 
model 
- Bonferoni Holm 
correction -> very strict 
- No TMV analysis 
Bichuetti 
(2013) 
81
 
CS 9 48  SD, 
Sp 
- Comparison of RNFL in RRMS, NMO and CRION 
- pRNFL and VA significantly worse in NMO (p=0.004) and CRION (p<0.0001) 
compared to RRMS after ON 
- No differences between NMO and CRION eyes  
- No TMV analysis 
Kaufhold 
(2013) 
58
 
RS, 
CS 
20 NMOSD 
(incl. AQP4+ 
LETM) 
219 
MS
, 39 
CIS 
121 SD, 
Sp 
- ON is associated with INL thickening and MME independently of MS 
- MME only in ON eyes (with 1 exception) 
- MME frequency in ON eyes:  
 6.3% in MS 
 21.0% in NMOSD  
Subgroup unilateral ON:  
ON compared to NON eyes reduced mRNFL thickness (p<0.001) and GCIP 
(p<0.001) but higher INL thickness (p<0.001) 
- No layer thicknesses 
for different disease 
cohorts 
Glehn 
(2014) 
73
 
CS 21 NMOSD 
(incl. AQP4+ 
LETM) 
 34 SD, 
Sp 
- Correlation of RNFL to MRI derived brain measures  
- pRNFL is significantly reduced in NMOSD compared to HC in average and all 
quadrants (all p<0.001) 
- Correlation between RNFL and pericalcarine cortical thickness 
- NMOSD is associated with grey and white matter atrophy 
- No macular analysis 
- No MS 
- No independent 
analysis for ON  
 
NON: eyes without history of optic neuritis; HC: healthy controls; OCT: optical coherence tomography; CRION: chronic inflammatory optic neuropathy; CIS: 
clinically isolated syndrome; p/mRNFL: peripapillary/macular retinal nerve fiber layer; TMV: total macular volume; GCL: ganglion cell layer; IPL: inner plexiform 
layer; GCIP: Ganglion cell and inner plexiform layer; INL: inner nuclear layer; VA: visual acuity; VF: visual field; CS: contrast sensitivity; LCVS: Low-contrast 
visual sensitivity; MME: Microcystic macular edema; n.s.: not significant;  
RNFL quadrants: I: inferior; S: superior; N: nasal; T: temporal;  
Comments: 
 Bold title: Either manuscript title or rough description of content  
 p-values mainly only for pRNFL values because these were used in most studies 
 
